Restoration Robotics (NASDAQ: HAIR) and Quidel (NASDAQ:QDEL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.
Insider & Institutional Ownership
25.9% of Restoration Robotics shares are held by institutional investors. Comparatively, 93.4% of Quidel shares are held by institutional investors. 22.0% of Quidel shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
This table compares Restoration Robotics and Quidel’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current ratings for Restoration Robotics and Quidel, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Restoration Robotics presently has a consensus target price of $8.75, indicating a potential upside of 49.32%. Quidel has a consensus target price of $54.20, indicating a potential upside of 11.34%. Given Restoration Robotics’ higher probable upside, equities analysts clearly believe Restoration Robotics is more favorable than Quidel.
Earnings and Valuation
This table compares Restoration Robotics and Quidel’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Restoration Robotics||$21.30 million||7.96||-$17.84 million||N/A||N/A|
|Quidel||$277.74 million||6.11||-$8.16 million||($0.24)||-202.83|
Quidel has higher revenue and earnings than Restoration Robotics.
Quidel beats Restoration Robotics on 7 of the 12 factors compared between the two stocks.
About Restoration Robotics
Restoration Robotics, Inc. is a medical device company. The Company designs and develops the ARTAS Robotic Hair Transplant System, a physician-assisted system to harvest follicular units directly from the scalp and create recipient implant sites using algorithms. It offers machine vision, image guidance, visual servoing and robotics, as well as develops interfaces to manage these technologies. With the ARTAS Hair Studio application, physicians design personalized recipient site patterns on a three-dimensional (3D) patient model and transfer the aesthetic plan to the ARTAS Robotic System. The ARTAS Hair Studio application is a 3D patient consultation tool. Using actual patient photographs, the physician can create a simulated hair transplant model, which may be shared with the patient. The ARTAS Hair Studio application allows the physician to develop aesthetic plans with direct input from the patient. It also offers a solution, The ARTAS Robotic procedure.
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women’s health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, MicroVue, FreshCells, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, Amplivue, Lyra and Thyretain.
Receive News & Ratings for Restoration Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Restoration Robotics and related companies with MarketBeat.com's FREE daily email newsletter.